83 related articles for article (PubMed ID: 2473757)
21. pSEM vectors: high level expression of antigenic determinants and protein domains.
Knapp S; Bröker M; Amann E
Biotechniques; 1990 Mar; 8(3):280-1. PubMed ID: 1691917
[No Abstract] [Full Text] [Related]
22. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
23. Nucleotide sequence of the cDNA and the derived amino acid sequence for the major antigenic protein of foot and mouth disease virus, type Asia 1 63/72.
Suryanarayana VV; Rao BU; Padayatty JD
Indian J Biochem Biophys; 1992 Feb; 29(1):20-4. PubMed ID: 1317347
[TBL] [Abstract][Full Text] [Related]
24. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1.
Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F
Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534
[TBL] [Abstract][Full Text] [Related]
25. Outer membrane PhoE protein of Escherichia coli as a carrier for foreign antigenic determinants: immunogenicity of epitopes of foot-and-mouth disease virus.
Agterberg M; Adriaanse H; Lankhof H; Meloen R; Tommassen J
Vaccine; 1990 Feb; 8(1):85-91. PubMed ID: 1690490
[TBL] [Abstract][Full Text] [Related]
26. Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus.
Blanco E; Garcia-Briones M; Sanz-Parra A; Gomes P; De Oliveira E; Valero ML; Andreu D; Ley V; Sobrino F
J Virol; 2001 Apr; 75(7):3164-74. PubMed ID: 11238843
[TBL] [Abstract][Full Text] [Related]
27. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
de Prat-Gay G
Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
[TBL] [Abstract][Full Text] [Related]
28. [Expression in Escherichia coli of the human leukocyte interferon alpha2 gene fused with N-terminal fragment of beta-galactosidase].
Petrenko VA; Tat'kov SI; Semenova LN; Il'ichev AA; Pozdniakov PI
Mol Gen Mikrobiol Virusol; 1988 Apr; (4):37-41. PubMed ID: 3136326
[TBL] [Abstract][Full Text] [Related]
29. [Synthesis and expression of the DNA fragment coding the antigenic determinant of the surface antigen protein of hepatitis B virus].
Smirnov VD; Sergienko OV; Skripkin EA; Dubichev AG; Lunin VG
Bioorg Khim; 1983 Oct; 9(10):1388-94. PubMed ID: 6207838
[TBL] [Abstract][Full Text] [Related]
30. [Study on the DNA vaccine against foot-and-mouth disease virus using the heavy chain constant region of swine IgG as the carrier for peptide epitopes].
Li GJ; Yan WY; Xu QX; Sheng ZT; Zheng ZX
Sheng Wu Gong Cheng Xue Bao; 2001 May; 17(3):322-4. PubMed ID: 11517610
[TBL] [Abstract][Full Text] [Related]
31. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
[TBL] [Abstract][Full Text] [Related]
32. Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus.
Carver JA; Esposito G; Viglino P; Fogolari F; Guichard G; Briand JP; Van Regenmortel MH; Brown F; Mascagni P
Biopolymers; 1997 Apr; 41(5):569-90. PubMed ID: 9095678
[TBL] [Abstract][Full Text] [Related]
33. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
Furler S; Paterna JC; Weibel M; Büeler H
Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
[TBL] [Abstract][Full Text] [Related]
34. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1.
Wigdorovitz A; Pérez Filgueira DM; Robertson N; Carrillo C; Sadir AM; Morris TJ; Borca MV
Virology; 1999 Nov; 264(1):85-91. PubMed ID: 10544132
[TBL] [Abstract][Full Text] [Related]
35. Expression of a foot-and-mouth disease virus immunodominant epitope by a filamentous bacteriophage vector.
Kim YJ; Lebreton F; Kaiser C; Crucière C; Rémond M
Arch Virol; 2004 Feb; 149(2):365-77. PubMed ID: 14745601
[TBL] [Abstract][Full Text] [Related]
36. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
[TBL] [Abstract][Full Text] [Related]
37. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
38. A recombinant fusion protein and DNA vaccines against foot-and-mouth disease virus type Asia 1 infection in guinea pigs.
Zhang Q; Zhu MW; Yang YQ; Shao M; Zhang ZY; Lan HY; Yan WY; Wu JJ; Zheng ZX
Acta Virol; 2003; 47(4):237-43. PubMed ID: 15068379
[TBL] [Abstract][Full Text] [Related]
39. Improved mimicry of a foot-and-mouth disease virus antigenic site by a viral peptide displayed on beta-galactosidase surface.
Benito A; Mateu MG; Villaverde A
Biotechnology (N Y); 1995 Aug; 13(8):801-4. PubMed ID: 9634810
[TBL] [Abstract][Full Text] [Related]
40. Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs.
Kitson JD; Burke KL; Pullen LA; Belsham GJ; Almond JW
J Virol; 1991 Jun; 65(6):3068-75. PubMed ID: 1709696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
